Association between visceral adiposity index and heart failure: A cross‐sectional study
Background Obesity is an important risk factor for heart failure (HF). Hypothesis Visceral adiposity index (VAI) is a simple metric for assessing obesity; however, the association between VAI and risk for HF has not been studied. Methods A cross‐sectional study involving 28 764 participants ≥18 year...
Saved in:
| Published in: | Clinical cardiology (Mahwah, N.J.) Vol. 46; no. 3; pp. 310 - 319 |
|---|---|
| Main Authors: | , , , , , , , , , |
| Format: | Journal Article |
| Language: | English |
| Published: |
United States
John Wiley & Sons, Inc
01.03.2023
John Wiley and Sons Inc |
| Subjects: | |
| ISSN: | 0160-9289, 1932-8737, 1932-8737 |
| Online Access: | Get full text |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
| Abstract | Background
Obesity is an important risk factor for heart failure (HF).
Hypothesis
Visceral adiposity index (VAI) is a simple metric for assessing obesity; however, the association between VAI and risk for HF has not been studied.
Methods
A cross‐sectional study involving 28 764 participants ≥18 years of age from the National Health and Nutrition Examination Survey (NHANES), 2009–2018, in the United States was performed. VAI was calculated using body mass index (BMI), waist circumference (WC), triglycerides (TG), and high‐density lipoprotein cholesterol. VAI was analyzed as a continuous and categorical variable to examine its association with HF. Subgroup analysis was also performed.
Results
The highest VAI (fourth quartile [Q4]) was found among males, BMI, systolic and diastolic blood pressure, WC, hypertension, diabetes, liver disease, coronary heart disease, smoking, total cholesterol, and TG. More participants in Q4 took β‐receptor blockers, angiotensin‐converting enzyme inhibitors/angiotensin II receptor blockers/angiotensin receptor‐neprilysin inhibitor, calcium channel blockers, and antidiabetic and antihyperlipidemic medications. Participants with HF exhibited greater VAI. A per‐unit increase in VAI resulted in a 4% increased risk for HF (odds ratio [OR] 1.04 [95% confidence interval (CI) 1.02–1.05]). After multivariable adjustment, compared with the lowest quartile, the OR for Q3 was 1.55 (95% CI 1.24–1.94). Subgroup analysis revealed no significant interactions between VAI and specific subgroups.
Conclusion
VAI was independently associated with the risk for HF. As a noninvasive index of visceral adiposity, VAI could be used for a “one shot” assessment of HF risk and may serve as a novel marker. |
|---|---|
| AbstractList | Obesity is an important risk factor for heart failure (HF).
Visceral adiposity index (VAI) is a simple metric for assessing obesity; however, the association between VAI and risk for HF has not been studied.
A cross-sectional study involving 28 764 participants ≥18 years of age from the National Health and Nutrition Examination Survey (NHANES), 2009-2018, in the United States was performed. VAI was calculated using body mass index (BMI), waist circumference (WC), triglycerides (TG), and high-density lipoprotein cholesterol. VAI was analyzed as a continuous and categorical variable to examine its association with HF. Subgroup analysis was also performed.
The highest VAI (fourth quartile [Q4]) was found among males, BMI, systolic and diastolic blood pressure, WC, hypertension, diabetes, liver disease, coronary heart disease, smoking, total cholesterol, and TG. More participants in Q4 took β-receptor blockers, angiotensin-converting enzyme inhibitors/angiotensin II receptor blockers/angiotensin receptor-neprilysin inhibitor, calcium channel blockers, and antidiabetic and antihyperlipidemic medications. Participants with HF exhibited greater VAI. A per-unit increase in VAI resulted in a 4% increased risk for HF (odds ratio [OR] 1.04 [95% confidence interval (CI) 1.02-1.05]). After multivariable adjustment, compared with the lowest quartile, the OR for Q3 was 1.55 (95% CI 1.24-1.94). Subgroup analysis revealed no significant interactions between VAI and specific subgroups.
VAI was independently associated with the risk for HF. As a noninvasive index of visceral adiposity, VAI could be used for a "one shot" assessment of HF risk and may serve as a novel marker. Background Obesity is an important risk factor for heart failure (HF). Hypothesis Visceral adiposity index (VAI) is a simple metric for assessing obesity; however, the association between VAI and risk for HF has not been studied. Methods A cross‐sectional study involving 28 764 participants ≥18 years of age from the National Health and Nutrition Examination Survey (NHANES), 2009–2018, in the United States was performed. VAI was calculated using body mass index (BMI), waist circumference (WC), triglycerides (TG), and high‐density lipoprotein cholesterol. VAI was analyzed as a continuous and categorical variable to examine its association with HF. Subgroup analysis was also performed. Results The highest VAI (fourth quartile [Q4]) was found among males, BMI, systolic and diastolic blood pressure, WC, hypertension, diabetes, liver disease, coronary heart disease, smoking, total cholesterol, and TG. More participants in Q4 took β‐receptor blockers, angiotensin‐converting enzyme inhibitors/angiotensin II receptor blockers/angiotensin receptor‐neprilysin inhibitor, calcium channel blockers, and antidiabetic and antihyperlipidemic medications. Participants with HF exhibited greater VAI. A per‐unit increase in VAI resulted in a 4% increased risk for HF (odds ratio [OR] 1.04 [95% confidence interval (CI) 1.02–1.05]). After multivariable adjustment, compared with the lowest quartile, the OR for Q3 was 1.55 (95% CI 1.24–1.94). Subgroup analysis revealed no significant interactions between VAI and specific subgroups. Conclusion VAI was independently associated with the risk for HF. As a noninvasive index of visceral adiposity, VAI could be used for a “one shot” assessment of HF risk and may serve as a novel marker. BackgroundObesity is an important risk factor for heart failure (HF).HypothesisVisceral adiposity index (VAI) is a simple metric for assessing obesity; however, the association between VAI and risk for HF has not been studied.MethodsA cross-sectional study involving 28 764 participants ≥18 years of age from the National Health and Nutrition Examination Survey (NHANES), 2009–2018, in the United States was performed. VAI was calculated using body mass index (BMI), waist circumference (WC), triglycerides (TG), and high-density lipoprotein cholesterol. VAI was analyzed as a continuous and categorical variable to examine its association with HF. Subgroup analysis was also performed.ResultsThe highest VAI (fourth quartile [Q4]) was found among males, BMI, systolic and diastolic blood pressure, WC, hypertension, diabetes, liver disease, coronary heart disease, smoking, total cholesterol, and TG. More participants in Q4 took β-receptor blockers, angiotensin-converting enzyme inhibitors/angiotensin II receptor blockers/angiotensin receptor-neprilysin inhibitor, calcium channel blockers, and antidiabetic and antihyperlipidemic medications. Participants with HF exhibited greater VAI. A per-unit increase in VAI resulted in a 4% increased risk for HF (odds ratio [OR] 1.04 [95% confidence interval (CI) 1.02–1.05]). After multivariable adjustment, compared with the lowest quartile, the OR for Q3 was 1.55 (95% CI 1.24–1.94). Subgroup analysis revealed no significant interactions between VAI and specific subgroups.ConclusionVAI was independently associated with the risk for HF. As a noninvasive index of visceral adiposity, VAI could be used for a “one shot” assessment of HF risk and may serve as a novel marker. Obesity is an important risk factor for heart failure (HF).BACKGROUNDObesity is an important risk factor for heart failure (HF).Visceral adiposity index (VAI) is a simple metric for assessing obesity; however, the association between VAI and risk for HF has not been studied.HYPOTHESISVisceral adiposity index (VAI) is a simple metric for assessing obesity; however, the association between VAI and risk for HF has not been studied.A cross-sectional study involving 28 764 participants ≥18 years of age from the National Health and Nutrition Examination Survey (NHANES), 2009-2018, in the United States was performed. VAI was calculated using body mass index (BMI), waist circumference (WC), triglycerides (TG), and high-density lipoprotein cholesterol. VAI was analyzed as a continuous and categorical variable to examine its association with HF. Subgroup analysis was also performed.METHODSA cross-sectional study involving 28 764 participants ≥18 years of age from the National Health and Nutrition Examination Survey (NHANES), 2009-2018, in the United States was performed. VAI was calculated using body mass index (BMI), waist circumference (WC), triglycerides (TG), and high-density lipoprotein cholesterol. VAI was analyzed as a continuous and categorical variable to examine its association with HF. Subgroup analysis was also performed.The highest VAI (fourth quartile [Q4]) was found among males, BMI, systolic and diastolic blood pressure, WC, hypertension, diabetes, liver disease, coronary heart disease, smoking, total cholesterol, and TG. More participants in Q4 took β-receptor blockers, angiotensin-converting enzyme inhibitors/angiotensin II receptor blockers/angiotensin receptor-neprilysin inhibitor, calcium channel blockers, and antidiabetic and antihyperlipidemic medications. Participants with HF exhibited greater VAI. A per-unit increase in VAI resulted in a 4% increased risk for HF (odds ratio [OR] 1.04 [95% confidence interval (CI) 1.02-1.05]). After multivariable adjustment, compared with the lowest quartile, the OR for Q3 was 1.55 (95% CI 1.24-1.94). Subgroup analysis revealed no significant interactions between VAI and specific subgroups.RESULTSThe highest VAI (fourth quartile [Q4]) was found among males, BMI, systolic and diastolic blood pressure, WC, hypertension, diabetes, liver disease, coronary heart disease, smoking, total cholesterol, and TG. More participants in Q4 took β-receptor blockers, angiotensin-converting enzyme inhibitors/angiotensin II receptor blockers/angiotensin receptor-neprilysin inhibitor, calcium channel blockers, and antidiabetic and antihyperlipidemic medications. Participants with HF exhibited greater VAI. A per-unit increase in VAI resulted in a 4% increased risk for HF (odds ratio [OR] 1.04 [95% confidence interval (CI) 1.02-1.05]). After multivariable adjustment, compared with the lowest quartile, the OR for Q3 was 1.55 (95% CI 1.24-1.94). Subgroup analysis revealed no significant interactions between VAI and specific subgroups.VAI was independently associated with the risk for HF. As a noninvasive index of visceral adiposity, VAI could be used for a "one shot" assessment of HF risk and may serve as a novel marker.CONCLUSIONVAI was independently associated with the risk for HF. As a noninvasive index of visceral adiposity, VAI could be used for a "one shot" assessment of HF risk and may serve as a novel marker. |
| Author | Wang, Yi Xiao, Jie Zhang, Xinyu Li, Ying Wang, Chengwei Lin, Zongwei Ji, Xiaoping Dong, Mei Sun, Yijun Lu, Huixia |
| AuthorAffiliation | 1 Key Laboratory of Cardiovascular Remodeling and Function Research, Chinese Ministry of Education, Chinese National Health Commission and Chinese Academy of Medical Sciences, State and Shandong Province Joint Key Laboratory of Translational Cardiovascular Medicine, Department of Cardiology, Qilu Hospital, Cheeloo College of Medicine Shandong University Jinan Shandong China |
| AuthorAffiliation_xml | – name: 1 Key Laboratory of Cardiovascular Remodeling and Function Research, Chinese Ministry of Education, Chinese National Health Commission and Chinese Academy of Medical Sciences, State and Shandong Province Joint Key Laboratory of Translational Cardiovascular Medicine, Department of Cardiology, Qilu Hospital, Cheeloo College of Medicine Shandong University Jinan Shandong China |
| Author_xml | – sequence: 1 givenname: Xinyu surname: Zhang fullname: Zhang, Xinyu organization: Shandong University – sequence: 2 givenname: Yijun surname: Sun fullname: Sun, Yijun organization: Shandong University – sequence: 3 givenname: Ying surname: Li fullname: Li, Ying organization: Shandong University – sequence: 4 givenname: Chengwei surname: Wang fullname: Wang, Chengwei organization: Shandong University – sequence: 5 givenname: Yi surname: Wang fullname: Wang, Yi organization: Shandong University – sequence: 6 givenname: Mei surname: Dong fullname: Dong, Mei organization: Shandong University – sequence: 7 givenname: Jie surname: Xiao fullname: Xiao, Jie organization: Shandong University – sequence: 8 givenname: Zongwei surname: Lin fullname: Lin, Zongwei organization: Shandong University – sequence: 9 givenname: Huixia orcidid: 0000-0003-0131-5808 surname: Lu fullname: Lu, Huixia email: luhuixia@sdu.edu.cn organization: Shandong University – sequence: 10 givenname: Xiaoping orcidid: 0000-0002-1935-2239 surname: Ji fullname: Ji, Xiaoping email: jixiaoping@sdu.edu.cn organization: Shandong University |
| BackLink | https://www.ncbi.nlm.nih.gov/pubmed/36651220$$D View this record in MEDLINE/PubMed |
| BookMark | eNp1kc9u1DAYxC1URLeFAy-AInGhh7T-FzvhUq1WhVZaqRc4cLIc-wt1lbUXO2nZG4_AM_IkOLtbRCs4-fD9ZjSeOUIHPnhA6DXBpwRjemZ6c0pZI8UzNCMNo2UtmTxAM0wELhtaN4foKKXbjOKashfokAlREUrxDH2ZpxSM04MLvmhhuAfwxZ1LBqLuC23dOiQ3bArnLXwvtLfFDeg4FJ12_RjhfTEvTAwp_frxM4GZXLIsDaPdvETPO90neLV_j9HnDxefFpfl8vrj1WK-LA3nXJTEsLrqbNtYZjABqavGtqyDpmNtxTnGEmwNvKoaaizvrOStFUJoUwleNaZlx-h857se2xVYA37I0dU6upWOGxW0U48v3t2or-FO5epITTDJDu_2DjF8GyENajUV0PfaQxiTolIISTHDNKNvn6C3YYz5zxNVSyykrCfqzd-R_mR5qD0DZztg212EThk3bDfICV2fo03pqMrDqu2wWXHyRPFg-i92737vetj8H1SL5WKn-A3CbrQg |
| CitedBy_id | crossref_primary_10_3389_fcvm_2024_1341229 crossref_primary_10_1089_met_2024_0128 crossref_primary_10_1186_s40795_024_00957_4 crossref_primary_10_14814_phy2_70382 crossref_primary_10_3390_diseases12060119 crossref_primary_10_1016_j_jnma_2024_10_007 crossref_primary_10_1038_s41598_025_11803_3 crossref_primary_10_29328_journal_niogb_1001022 crossref_primary_10_1002_ehf2_14935 crossref_primary_10_3389_fcvm_2024_1433950 crossref_primary_10_3389_fnut_2023_1107637 crossref_primary_10_1016_j_exger_2024_112578 crossref_primary_10_1186_s40001_025_02340_w crossref_primary_10_1016_j_jnha_2024_100323 crossref_primary_10_3390_nu17142374 crossref_primary_10_1038_s41598_024_67430_x crossref_primary_10_1016_j_arth_2025_07_073 crossref_primary_10_1186_s12944_025_02654_y crossref_primary_10_21886_2219_8075_2025_16_2_75_82 crossref_primary_10_2147_DMSO_S484545 crossref_primary_10_3389_fendo_2023_1322445 crossref_primary_10_1038_s41598_025_01848_9 crossref_primary_10_1080_14796678_2025_2479378 crossref_primary_10_14341_omet13055 crossref_primary_10_3389_fnut_2025_1556886 crossref_primary_10_3389_fneur_2025_1540182 crossref_primary_10_3389_fendo_2025_1542516 crossref_primary_10_3389_fendo_2023_1296398 |
| Cites_doi | 10.1038/nrcardio.2017.65 10.1016/j.numecd.2021.04.024 10.1161/CIR.0000000000000485 10.3390/nu13041166 10.3389/fcvm.2021.702489 10.7326/0003-4819-150-9-200905050-00006 10.1016/j.jacc.2018.10.024 10.1007/s40519-020-00982-9 10.1161/CIR.0000000000000450 10.1093/eurheartj/ehaa823 10.1016/j.numecd.2020.01.013 10.1016/j.dsx.2019.01.056 10.1016/j.jacc.2017.09.006 10.1186/s12967-019-2074-1 10.1016/j.numecd.2021.02.032 10.1590/1516-3180.2015.01452111 10.1016/j.jchf.2018.07.009 10.1038/hr.2011.157 10.1002/ejhf.1956 10.1002/ejhf.1629 10.7326/M14-2525 10.1016/j.pcad.2018.07.003 10.1161/CIRCULATIONAHA.108.807289 10.1016/j.jcmg.2020.07.022 10.1507/endocrj.EJ19-0008 10.1056/NEJMoa020245 10.1080/00015385.2019.1686226 10.1161/CIR.0000000000000659 10.1093/eurheartj/ehaa1034 10.1161/CIRCULATIONAHA.109.887893 10.1016/j.pcad.2018.06.004 10.1093/eurheartj/ehab368 10.1136/bmjdrc-2020-001681 10.1080/07853890.2016.1197415 10.1016/j.jacc.2011.11.040 10.1080/14779072.2017.1352471 10.1161/CIRCIMAGING.113.000532 |
| ContentType | Journal Article |
| Copyright | 2023 The Authors. published by Wiley Periodicals, LLC. 2023 The Authors. Clinical Cardiology published by Wiley Periodicals, LLC. 2023. This work is published under http://creativecommons.org/licenses/by/4.0/ (the “License”). Notwithstanding the ProQuest Terms and Conditions, you may use this content in accordance with the terms of the License. |
| Copyright_xml | – notice: 2023 The Authors. published by Wiley Periodicals, LLC. – notice: 2023 The Authors. Clinical Cardiology published by Wiley Periodicals, LLC. – notice: 2023. This work is published under http://creativecommons.org/licenses/by/4.0/ (the “License”). Notwithstanding the ProQuest Terms and Conditions, you may use this content in accordance with the terms of the License. |
| DBID | 24P AAYXX CITATION CGR CUY CVF ECM EIF NPM 3V. 7X7 7XB 8FI 8FJ 8FK ABUWG AFKRA AZQEC BENPR CCPQU DWQXO FYUFA GHDGH K9. M0S PHGZM PHGZT PIMPY PJZUB PKEHL PPXIY PQEST PQQKQ PQUKI PRINS 7X8 5PM |
| DOI | 10.1002/clc.23976 |
| DatabaseName | Wiley Online Library Open Access CrossRef Medline MEDLINE MEDLINE (Ovid) MEDLINE MEDLINE PubMed ProQuest Central (Corporate) Proquest Health and Medical Complete ProQuest Central (purchase pre-March 2016) ProQuest Hospital Collection Hospital Premium Collection (Alumni Edition) ProQuest Central (Alumni) (purchase pre-March 2016) ProQuest Central (Alumni) ProQuest Central UK/Ireland ProQuest Central Essentials ProQuest Central ProQuest One Community College ProQuest Central Health Research Premium Collection Health Research Premium Collection (Alumni) ProQuest Health & Medical Complete (Alumni) ProQuest Health & Medical Collection ProQuest Central Premium ProQuest One Academic Publicly Available Content Database ProQuest Health & Medical Research Collection ProQuest One Academic Middle East (New) ProQuest One Health & Nursing ProQuest One Academic Eastern Edition (DO NOT USE) ProQuest One Academic (retired) ProQuest One Academic UKI Edition ProQuest Central China MEDLINE - Academic PubMed Central (Full Participant titles) |
| DatabaseTitle | CrossRef MEDLINE Medline Complete MEDLINE with Full Text PubMed MEDLINE (Ovid) Publicly Available Content Database ProQuest One Academic Middle East (New) ProQuest Central Essentials ProQuest One Academic Eastern Edition ProQuest Health & Medical Complete (Alumni) ProQuest Central (Alumni Edition) ProQuest One Community College ProQuest Hospital Collection Health Research Premium Collection (Alumni) ProQuest One Health & Nursing ProQuest Central China ProQuest Hospital Collection (Alumni) ProQuest Central ProQuest Health & Medical Complete ProQuest Health & Medical Research Collection Health Research Premium Collection ProQuest One Academic UKI Edition Health and Medicine Complete (Alumni Edition) ProQuest Central Korea ProQuest Central (New) ProQuest One Academic ProQuest One Academic (New) ProQuest Central (Alumni) MEDLINE - Academic |
| DatabaseTitleList | MEDLINE Publicly Available Content Database MEDLINE - Academic |
| Database_xml | – sequence: 1 dbid: 24P name: Wiley Online Library Open Access url: https://authorservices.wiley.com/open-science/open-access/browse-journals.html sourceTypes: Publisher – sequence: 2 dbid: NPM name: PubMed url: http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?db=PubMed sourceTypes: Index Database – sequence: 3 dbid: PIMPY name: Publicly Available Content Database url: http://search.proquest.com/publiccontent sourceTypes: Aggregation Database |
| DeliveryMethod | fulltext_linktorsrc |
| Discipline | Medicine |
| DocumentTitleAlternate | ZHANG et al |
| EISSN | 1932-8737 |
| EndPage | 319 |
| ExternalDocumentID | PMC10018101 36651220 10_1002_clc_23976 CLC23976 |
| Genre | article Journal Article |
| GeographicLocations | United States--US |
| GeographicLocations_xml | – name: United States--US |
| GrantInformation_xml | – fundername: National Natural Science Foundation of China funderid: 81873516; 81900444; 82170463 – fundername: Natural Science Foundation of Shandong Province funderid: ZR2019BH052; ZR2019PH030; ZR2020QH007 – fundername: National Key Research and Development Program of China funderid: 2021YFF0501404; 2021YFF0501403 – fundername: China International Medical Foundation funderid: Z‐2016‐23‐2001‐01; Z‐2019‐42‐1908‐2 – fundername: Clinical Research Center of Shandong University funderid: 2020SDUCRCA009 – fundername: Natural Science Foundation of Shandong Province grantid: ZR2019BH052 – fundername: Natural Science Foundation of Shandong Province grantid: ZR2020QH007 – fundername: National Key Research and Development Program of China grantid: 2021YFF0501403 – fundername: Clinical Research Center of Shandong University grantid: 2020SDUCRCA009 – fundername: China International Medical Foundation grantid: Z-2019-42-1908-2 – fundername: China International Medical Foundation grantid: Z-2016-23-2001-01 – fundername: Natural Science Foundation of Shandong Province grantid: ZR2019PH030 – fundername: National Key Research and Development Program of China grantid: 2021YFF0501404 – fundername: National Natural Science Foundation of China grantid: 81873516 – fundername: National Natural Science Foundation of China grantid: 82170463 – fundername: ; grantid: Z‐2016‐23‐2001‐01; Z‐2019‐42‐1908‐2 – fundername: ; grantid: ZR2019BH052; ZR2019PH030; ZR2020QH007 – fundername: National Key Research and Development Program of China grantid: 2021YFF0501404; 2021YFF0501403 – fundername: ; grantid: 81873516; 81900444; 82170463 |
| GroupedDBID | --- .GJ 05W 0R~ 10A 1OC 24P 29B 31~ 4.4 50Y 51W 51X 52M 52N 52P 52R 52S 52X 53G 5GY 5RE 5VS 7PT 7X7 8-1 8FI 8FJ 8UM AAHHS AAZKR ABCQN ABEML ABOCM ABUWG ACCFJ ACCMX ACSCC ACXQS ADBBV ADKYN ADZMN ADZOD AEEZP AENEX AEQDE AFBPY AFKRA AFPKN AHMBA AIWBW AJBDE ALAGY ALIPV ALMA_UNASSIGNED_HOLDINGS ALUQN AVUZU BCNDV BENPR BFHJK BY8 CCPQU CS3 DU5 EBS EJD EMOBN F5P FYUFA G-S GODZA GROUPED_DOAJ HF~ HMCUK HYE HZ~ IAO IHR INH ITC J0M LAW LC2 LC3 LH4 LW6 MY~ O9- OIG OK1 P6G PIMPY PQQKQ Q11 QRW RPM RX1 SUPJJ TR2 UKHRP WIN WQJ WXI XG1 XV2 ZGI ZXP 1OB AAFWJ AAMMB AAYXX AEFGJ AFFHD AGXDD AIDQK AIDYY CITATION PHGZM PHGZT CGR CUY CVF ECM EIF NPM 3V. 7XB 8FK AZQEC DWQXO K9. PJZUB PKEHL PPXIY PQEST PQUKI PRINS 7X8 PUEGO 5PM |
| ID | FETCH-LOGICAL-c4446-1c385fdb9d3c01e7a59db3fe9f3b544007ed8e45592cd4fd74bd666ac56459cb3 |
| IEDL.DBID | 24P |
| ISICitedReferencesCount | 33 |
| ISICitedReferencesURI | http://www.webofscience.com/api/gateway?GWVersion=2&SrcApp=Summon&SrcAuth=ProQuest&DestLinkType=CitingArticles&DestApp=WOS_CPL&KeyUT=000916236500001&url=https%3A%2F%2Fcvtisr.summon.serialssolutions.com%2F%23%21%2Fsearch%3Fho%3Df%26include.ft.matches%3Dt%26l%3Dnull%26q%3D |
| ISSN | 0160-9289 1932-8737 |
| IngestDate | Tue Nov 04 02:07:06 EST 2025 Fri Sep 05 14:09:24 EDT 2025 Sat Nov 29 14:42:39 EST 2025 Mon Jul 21 06:07:50 EDT 2025 Tue Nov 18 21:59:08 EST 2025 Sat Nov 29 02:18:35 EST 2025 Wed Jan 22 16:14:31 EST 2025 |
| IsDoiOpenAccess | true |
| IsOpenAccess | true |
| IsPeerReviewed | true |
| IsScholarly | true |
| Issue | 3 |
| Keywords | heart failure visceral adiposity index visceral fat VAI |
| Language | English |
| License | Attribution 2023 The Authors. Clinical Cardiology published by Wiley Periodicals, LLC. This is an open access article under the terms of the http://creativecommons.org/licenses/by/4.0/ License, which permits use, distribution and reproduction in any medium, provided the original work is properly cited. |
| LinkModel | DirectLink |
| MergedId | FETCHMERGED-LOGICAL-c4446-1c385fdb9d3c01e7a59db3fe9f3b544007ed8e45592cd4fd74bd666ac56459cb3 |
| Notes | Xinyu Zhang and Yijun Sun are co‐first authors. ObjectType-Article-1 SourceType-Scholarly Journals-1 ObjectType-Feature-2 content type line 14 content type line 23 |
| ORCID | 0000-0003-0131-5808 0000-0002-1935-2239 |
| OpenAccessLink | https://onlinelibrary.wiley.com/doi/abs/10.1002%2Fclc.23976 |
| PMID | 36651220 |
| PQID | 2787067782 |
| PQPubID | 946375 |
| PageCount | 10 |
| ParticipantIDs | pubmedcentral_primary_oai_pubmedcentral_nih_gov_10018101 proquest_miscellaneous_2766720302 proquest_journals_2787067782 pubmed_primary_36651220 crossref_citationtrail_10_1002_clc_23976 crossref_primary_10_1002_clc_23976 wiley_primary_10_1002_clc_23976_CLC23976 |
| PublicationCentury | 2000 |
| PublicationDate | March 2023 |
| PublicationDateYYYYMMDD | 2023-03-01 |
| PublicationDate_xml | – month: 03 year: 2023 text: March 2023 |
| PublicationDecade | 2020 |
| PublicationPlace | United States |
| PublicationPlace_xml | – name: United States – name: Hoboken |
| PublicationTitle | Clinical cardiology (Mahwah, N.J.) |
| PublicationTitleAlternate | Clin Cardiol |
| PublicationYear | 2023 |
| Publisher | John Wiley & Sons, Inc John Wiley and Sons Inc |
| Publisher_xml | – name: John Wiley & Sons, Inc – name: John Wiley and Sons Inc |
| References | 2021; 8 2015; 163 2021; 26 2021; 42 2019; 13 2019; 17 2010; 121 2009; 150 2018; 61 2012; 59 2009; 119 2012; 35 2017; 135 2013; 6 2018; 46 2021; 14 2020; 8 2021; 13 2018; 6 2021; 76 2021; 31 2017; 70 2017; 15 2017; 14 2020; 30 2019; 21 2016; 134 2017 2002; 347 2020; 67 2019; 139 2020; 22 2018; 72 2016; 48 Heart Failure Group of Chinese Society of Cardiology of Chinese Medical A, Chinese Heart Failure Association of Chinese Medical Doctor A, Editorial Board of Chinese Journal of C (e_1_2_9_3_1) 2018; 46 e_1_2_9_30_1 e_1_2_9_31_1 Fryar CD (e_1_2_9_20_1) 2017 e_1_2_9_11_1 e_1_2_9_34_1 e_1_2_9_10_1 e_1_2_9_35_1 e_1_2_9_13_1 e_1_2_9_32_1 e_1_2_9_12_1 e_1_2_9_33_1 e_1_2_9_15_1 e_1_2_9_38_1 e_1_2_9_14_1 e_1_2_9_39_1 e_1_2_9_17_1 e_1_2_9_36_1 e_1_2_9_16_1 e_1_2_9_37_1 e_1_2_9_19_1 e_1_2_9_18_1 e_1_2_9_40_1 e_1_2_9_22_1 e_1_2_9_21_1 e_1_2_9_24_1 e_1_2_9_23_1 e_1_2_9_8_1 e_1_2_9_7_1 e_1_2_9_6_1 e_1_2_9_5_1 e_1_2_9_4_1 e_1_2_9_2_1 e_1_2_9_9_1 e_1_2_9_26_1 e_1_2_9_25_1 e_1_2_9_28_1 e_1_2_9_27_1 e_1_2_9_29_1 |
| References_xml | – volume: 21 start-page: 1329 issue: 11 year: 2019 end-page: 1337 article-title: Prevalence of heart failure and left ventricular dysfunction in China: the China Hypertension Survey, 2012–2015 publication-title: Eur J Heart Fail – volume: 15 start-page: 567 issue: 8 year: 2017 end-page: 579 article-title: Effect of bariatric surgery on heart failure publication-title: Expert Rev Cardiovasc Ther – volume: 121 start-page: 237 issue: 2 year: 2010 end-page: 244 article-title: Joint effects of physical activity, body mass index, waist circumference, and waist‐to‐hip ratio on the risk of heart failure publication-title: Circulation – volume: 135 start-page: e146 issue: 10 year: 2017 end-page: e603 article-title: Heart disease and stroke statistics‐2017 update: a report from the American Heart Association publication-title: Circulation – volume: 139 start-page: e56 issue: 10 year: 2019 end-page: e528 article-title: Heart disease and stroke statistics‐2019 update: a report from the American Heart Association publication-title: Circulation – volume: 42 start-page: 896 issue: 9 year: 2021 end-page: 903 article-title: The neutrophil‐lymphocyte ratio and incident atherosclerotic events: analyses from five contemporary randomized trials publication-title: Eur Heart J – volume: 61 start-page: 103 issue: 2 year: 2018 end-page: 113 article-title: Overview of epidemiology and contribution of obesity and body fat distribution to cardiovascular disease: an update publication-title: Prog Cardiovasc Dis – volume: 134 start-page: 211 issue: 3 year: 2016 end-page: 218 article-title: Visceral adiposity index and prognosis among patients with ischemic heart failure publication-title: Sao Paulo Med J – start-page: 1 issue: 289 year: 2017 end-page: 8 article-title: Hypertension prevalence and control among adults: United States, 2015‐2016 publication-title: NCHS Data Brief – volume: 22 start-page: 1540 issue: 9 year: 2020 end-page: 1550 article-title: Regional adiposity and heart failure with preserved ejection fraction publication-title: Eur J Heart Fail – volume: 347 start-page: 305 issue: 5 year: 2002 end-page: 313 article-title: Obesity and the risk of heart failure publication-title: N Engl J Med – volume: 119 start-page: 44 issue: 1 year: 2009 end-page: 52 article-title: Body mass index and vigorous physical activity and the risk of heart failure among men publication-title: Circulation – volume: 35 start-page: 186 issue: 2 year: 2012 end-page: 193 article-title: Cardiac remodeling and diastolic dysfunction in DahlS.Z‐Lepr(fa)/Lepr(fa) rats: a new animal model of metabolic syndrome publication-title: Hypertension Res – volume: 26 start-page: 1697 issue: 6 year: 2021 end-page: 1707 article-title: Obesity paradox and heart failure publication-title: Eat Weight Disord – volume: 8 year: 2021 article-title: Association between dietary inflammatory index and heart failure: results from NHANES (1999–2018) publication-title: Front Cardiovasc Med – volume: 6 start-page: 999 issue: 12 year: 2018 end-page: 1007 article-title: Adiposity and incident heart failure and its subtypes publication-title: JACC Heart Fail – volume: 31 start-page: 1774 issue: 6 year: 2021 end-page: 1781 article-title: Association of the new visceral adiposity index with coronary artery calcification and arterial stiffness in Korean population publication-title: Nutr Metab Cardiovasc Dis – volume: 72 start-page: 3027 issue: 23 pt B year: 2018 end-page: 3052 article-title: Reprint of: healthy weight and obesity prevention publication-title: JACC – volume: 14 start-page: 203 issue: 1 year: 2021 end-page: 215 article-title: Body composition, natriuretic peptides, and adverse outcomes in heart failure with preserved and reduced ejection fraction publication-title: JACC Cardiovasc Imaging – volume: 6 start-page: 800 issue: 5 year: 2013 end-page: 807 article-title: Relation of regional fat distribution to left ventricular structure and function publication-title: Circ Cardiovasc Imaging – volume: 17 start-page: 341 issue: 1 year: 2019 article-title: Visceral adipose accumulation increased the risk of hyperuricemia among middle‐aged and elderly adults: a population‐based study publication-title: J Transl Med – volume: 42 start-page: 1595 issue: 16 year: 2021 end-page: 1605 article-title: Pathophysiologic importance of visceral adipose tissue in women with heart failure and preserved ejection fraction publication-title: Eur Heart J – volume: 70 start-page: 2186 issue: 17 year: 2017 end-page: 2200 article-title: Biological phenotypes of heart failure with preserved ejection fraction publication-title: JACC – volume: 13 start-page: 1231 issue: 2 year: 2019 end-page: 1235 article-title: Visceral adiposity index as a predictor for type 2 diabetes mellitus in Asian population: a systematic review publication-title: Diabetes Metab Syndr – volume: 30 start-page: 796 issue: 5 year: 2020 end-page: 803 article-title: Association between coronary atherosclerosis and visceral adiposity index publication-title: Nutr Metab Cardiovasc Dis – volume: 48 start-page: 603 issue: 8 year: 2016 end-page: 613 article-title: Complex relationship of obesity and obesity paradox in heart failure—higher risk of developing heart failure and better outcomes in established heart failure publication-title: Ann Med – volume: 59 start-page: 998 issue: 11 year: 2012 end-page: 1005 article-title: Impact of noncardiac comorbidities on morbidity and mortality in a predominantly male population with heart failure and preserved versus reduced ejection fraction publication-title: JACC – volume: 31 start-page: 2358 issue: 8 year: 2021 end-page: 2365 article-title: Association between visceral adipose index and risk of hypertension in a middle‐aged and elderly Chinese population publication-title: Nutr Metab Cardiovasc Dis – volume: 163 start-page: 827 issue: 11 year: 2015 end-page: 835 article-title: Normal‐weight central obesity: implications for total and cardiovascular mortality publication-title: Ann Intern Med – volume: 42 start-page: 3599 issue: 36 year: 2021 end-page: 3726 article-title: 2021 ESC Guidelines for the diagnosis and treatment of acute and chronic heart failure publication-title: Eur Heart J – volume: 14 start-page: 591 issue: 10 year: 2017 end-page: 602 article-title: Epidemiology of heart failure with preserved ejection fraction publication-title: Nat Rev Cardiol – volume: 67 start-page: 45 issue: 1 year: 2020 end-page: 52 article-title: Visceral adiposity index and longitudinal risk of incident metabolic syndrome: Korean genome and epidemiology study (KoGES) publication-title: Endocr J – volume: 13 start-page: 1166 issue: 4 year: 2021 article-title: The dietary inflammatory index is associated with low muscle mass and low muscle function in older Australians publication-title: Nutrients – volume: 134 start-page: e535 issue: 23 year: 2016 end-page: e578 article-title: Contributory risk and management of comorbidities of hypertension, obesity, diabetes mellitus, hyperlipidemia, and metabolic syndrome in chronic heart failure: a scientific statement from the American Heart Association publication-title: Circulation – volume: 46 start-page: 760 issue: 10 year: 2018 end-page: 789 article-title: Chinese guidelines for the diagnosis and treatment of heart failure 2018 publication-title: Zhonghua Xin Xue Guan Bing Za Zhi – volume: 8 issue: 1 year: 2020 article-title: Dietary intake of adults with and without diabetes: results from NHANES 2013‐2016 publication-title: BMJ Open Diabetes Res Care – volume: 150 start-page: 604 issue: 9 year: 2009 end-page: 612 article-title: A new equation to estimate glomerular filtration rate publication-title: Ann Intern Med – volume: 61 start-page: 142 issue: 2 year: 2018 end-page: 150 article-title: An overview and update on obesity and the obesity paradox in cardiovascular diseases publication-title: Prog Cardiovasc Dis – volume: 76 start-page: 20 issue: 1 year: 2021 end-page: 29 article-title: Determinants of maximal dose titration of sacubitril/valsartan in clinical practice publication-title: Acta Cardiol – ident: e_1_2_9_9_1 doi: 10.1038/nrcardio.2017.65 – ident: e_1_2_9_18_1 doi: 10.1016/j.numecd.2021.04.024 – ident: e_1_2_9_5_1 doi: 10.1161/CIR.0000000000000485 – ident: e_1_2_9_23_1 doi: 10.3390/nu13041166 – ident: e_1_2_9_24_1 doi: 10.3389/fcvm.2021.702489 – ident: e_1_2_9_22_1 doi: 10.7326/0003-4819-150-9-200905050-00006 – ident: e_1_2_9_30_1 doi: 10.1016/j.jacc.2018.10.024 – ident: e_1_2_9_10_1 doi: 10.1007/s40519-020-00982-9 – ident: e_1_2_9_28_1 doi: 10.1161/CIR.0000000000000450 – ident: e_1_2_9_12_1 doi: 10.1093/eurheartj/ehaa823 – ident: e_1_2_9_14_1 doi: 10.1016/j.numecd.2020.01.013 – ident: e_1_2_9_15_1 doi: 10.1016/j.dsx.2019.01.056 – ident: e_1_2_9_7_1 doi: 10.1016/j.jacc.2017.09.006 – ident: e_1_2_9_16_1 doi: 10.1186/s12967-019-2074-1 – volume: 46 start-page: 760 issue: 10 year: 2018 ident: e_1_2_9_3_1 article-title: Chinese guidelines for the diagnosis and treatment of heart failure 2018 publication-title: Zhonghua Xin Xue Guan Bing Za Zhi – ident: e_1_2_9_19_1 doi: 10.1016/j.numecd.2021.02.032 – ident: e_1_2_9_37_1 doi: 10.1590/1516-3180.2015.01452111 – ident: e_1_2_9_36_1 doi: 10.1016/j.jchf.2018.07.009 – ident: e_1_2_9_38_1 doi: 10.1038/hr.2011.157 – ident: e_1_2_9_11_1 doi: 10.1002/ejhf.1956 – ident: e_1_2_9_6_1 doi: 10.1002/ejhf.1629 – ident: e_1_2_9_35_1 doi: 10.7326/M14-2525 – ident: e_1_2_9_31_1 doi: 10.1016/j.pcad.2018.07.003 – ident: e_1_2_9_32_1 doi: 10.1161/CIRCULATIONAHA.108.807289 – ident: e_1_2_9_13_1 doi: 10.1016/j.jcmg.2020.07.022 – ident: e_1_2_9_17_1 doi: 10.1507/endocrj.EJ19-0008 – ident: e_1_2_9_27_1 doi: 10.1056/NEJMoa020245 – ident: e_1_2_9_25_1 doi: 10.1080/00015385.2019.1686226 – ident: e_1_2_9_4_1 doi: 10.1161/CIR.0000000000000659 – ident: e_1_2_9_26_1 doi: 10.1093/eurheartj/ehaa1034 – ident: e_1_2_9_29_1 doi: 10.1161/CIRCULATIONAHA.109.887893 – ident: e_1_2_9_34_1 doi: 10.1016/j.pcad.2018.06.004 – ident: e_1_2_9_2_1 doi: 10.1093/eurheartj/ehab368 – start-page: 1 issue: 289 year: 2017 ident: e_1_2_9_20_1 article-title: Hypertension prevalence and control among adults: United States, 2015‐2016 publication-title: NCHS Data Brief – ident: e_1_2_9_21_1 doi: 10.1136/bmjdrc-2020-001681 – ident: e_1_2_9_33_1 doi: 10.1080/07853890.2016.1197415 – ident: e_1_2_9_8_1 doi: 10.1016/j.jacc.2011.11.040 – ident: e_1_2_9_39_1 doi: 10.1080/14779072.2017.1352471 – ident: e_1_2_9_40_1 doi: 10.1161/CIRCIMAGING.113.000532 |
| SSID | ssj0020823 |
| Score | 2.4918213 |
| Snippet | Background
Obesity is an important risk factor for heart failure (HF).
Hypothesis
Visceral adiposity index (VAI) is a simple metric for assessing obesity;... Obesity is an important risk factor for heart failure (HF). Visceral adiposity index (VAI) is a simple metric for assessing obesity; however, the association... BackgroundObesity is an important risk factor for heart failure (HF).HypothesisVisceral adiposity index (VAI) is a simple metric for assessing obesity;... Obesity is an important risk factor for heart failure (HF).BACKGROUNDObesity is an important risk factor for heart failure (HF).Visceral adiposity index (VAI)... |
| SourceID | pubmedcentral proquest pubmed crossref wiley |
| SourceType | Open Access Repository Aggregation Database Index Database Enrichment Source Publisher |
| StartPage | 310 |
| SubjectTerms | Adiposity Age Anemia Antidiabetics Blood pressure Body Mass Index Cardiovascular disease Cholesterol, HDL Clinical Investigations Cross-Sectional Studies Diabetes Ejection fraction Epidemiology Ethics Glucose Heart attacks Heart failure Heart Failure - complications Heart Failure - diagnosis Heart Failure - epidemiology Hemoglobin Humans Hypertension Kidney diseases Laboratories Liver diseases Magnetic resonance imaging Male Nutrition Surveys Obesity Obesity - complications Obesity - diagnosis Obesity - epidemiology Obesity, Abdominal - complications Obesity, Abdominal - diagnosis Obesity, Abdominal - epidemiology Overweight Review boards Risk Factors Smoking Software Triglycerides VAI Variables visceral adiposity index visceral fat |
| SummonAdditionalLinks | – databaseName: ProQuest Central dbid: BENPR link: http://cvtisr.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwpV1LT9wwEB7BglAvLc-yLSCDOHCxyDrOw1wQXYE4tCtUFcEtcsaJiARZIAtS_309jjdlBe2FWySP5DgzHs94Jt8HsB8mxsbd8YAL1IJbhxdxFaPhIk9VFCHmeYSObCIZjdLra3XhL9wa31Y59YnOUZsx0h35oSDLIrQzcXz_wIk1iqqrnkJjHhYIqUz2YOHb6ejiZ5dyUR2pRfcOuLK5xRRbKBCH9LOzoNN49kR6FWa-7pZ8GcW6Y-js03sXsAwffQDKTlqLWYG5ol6FpR--xL4GVy8UxnwXF3uuGqTLK6ZN5dq8fjMHs8h0bRhxYk9YqSvqcD9iJ8ytkzeuyYvmchC263B5dvpreM49-wJHaXNEPsAwjUqTKxNiMCgSHSmTh2WhyjCPJNGpFyYtpM1IBBpZmkTmxuZCGh0-DebhBvTqcV1sApNppLSwLl5LlAMtlU5Qah0GwtgEPFB9OJhqIEMPTU4MGbdZC6osMquszCmrD3ud6H2Lx_GW0NZUBZnfkk329_v3YbcbvqPvd0t9xeMnkoljqksHVuZzq_VuljCObXAkgj6kM_bQCRBQ9-xIXd04wG7CuSIgNbtOZzr_fvNs-H3oHr78fwlf4QPx3rfNcFvQmzw-FduwiM-Tqnnc8bvgD1YjEc0 priority: 102 providerName: ProQuest |
| Title | Association between visceral adiposity index and heart failure: A cross‐sectional study |
| URI | https://onlinelibrary.wiley.com/doi/abs/10.1002%2Fclc.23976 https://www.ncbi.nlm.nih.gov/pubmed/36651220 https://www.proquest.com/docview/2787067782 https://www.proquest.com/docview/2766720302 https://pubmed.ncbi.nlm.nih.gov/PMC10018101 |
| Volume | 46 |
| WOSCitedRecordID | wos000916236500001&url=https%3A%2F%2Fcvtisr.summon.serialssolutions.com%2F%23%21%2Fsearch%3Fho%3Df%26include.ft.matches%3Dt%26l%3Dnull%26q%3D |
| hasFullText | 1 |
| inHoldings | 1 |
| isFullTextHit | |
| isPrint | |
| journalDatabaseRights | – providerCode: PRVAON databaseName: DOAJ (Directory of Open Access Journals) eJournal Collection customDbUrl: eissn: 1932-8737 dateEnd: 99991231 omitProxy: false ssIdentifier: ssj0020823 issn: 0160-9289 databaseCode: DOA dateStart: 20190101 isFulltext: true titleUrlDefault: https://www.doaj.org/ providerName: Directory of Open Access Journals – providerCode: PRVPQU databaseName: ProQuest Central customDbUrl: eissn: 1932-8737 dateEnd: 99991231 omitProxy: false ssIdentifier: ssj0020823 issn: 0160-9289 databaseCode: BENPR dateStart: 20190101 isFulltext: true titleUrlDefault: https://www.proquest.com/central providerName: ProQuest – providerCode: PRVPQU databaseName: ProQuest Central Health & Medical Collection (via ProQuest) customDbUrl: eissn: 1932-8737 dateEnd: 99991231 omitProxy: false ssIdentifier: ssj0020823 issn: 0160-9289 databaseCode: 7X7 dateStart: 20190101 isFulltext: true titleUrlDefault: https://search.proquest.com/healthcomplete providerName: ProQuest – providerCode: PRVPQU databaseName: Publicly Available Content Database customDbUrl: eissn: 1932-8737 dateEnd: 99991231 omitProxy: false ssIdentifier: ssj0020823 issn: 0160-9289 databaseCode: PIMPY dateStart: 20190101 isFulltext: true titleUrlDefault: http://search.proquest.com/publiccontent providerName: ProQuest – providerCode: PRVWIB databaseName: Wiley Online Library Free Content customDbUrl: eissn: 1932-8737 dateEnd: 99991231 omitProxy: false ssIdentifier: ssj0020823 issn: 0160-9289 databaseCode: WIN dateStart: 19780101 isFulltext: true titleUrlDefault: https://onlinelibrary.wiley.com providerName: Wiley-Blackwell – providerCode: PRVWIB databaseName: Wiley Online Library Open Access customDbUrl: eissn: 1932-8737 dateEnd: 99991231 omitProxy: false ssIdentifier: ssj0020823 issn: 0160-9289 databaseCode: 24P dateStart: 20190101 isFulltext: true titleUrlDefault: https://authorservices.wiley.com/open-science/open-access/browse-journals.html providerName: Wiley-Blackwell |
| link | http://cvtisr.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwpV1LT9wwEB7xqFAvhUJpl9KVQRy4RCS283B7ghUIpLKKUFGXU-RHIiItoSILUm_8BH4jv6QeJ5uyokiVuFixPJEf47Fn7PE3ADssNlbvjgKPakk9u-CFnoi08ahKRBhqrVSoXbCJeDhMRiORzsG36VuYBh-iO3BDyXDrNQq4VPXeX9BQfKxMcTedh8UgYAnGbaA87awtvEJqgL19T1izYgor5NO97tfZzeiZhvncUfKpAut2oKPlV7V9Bd61iifZb2bKe5jLq1VYOm2v1tfg4gmjSOu9Re7KWuOhFZGmdO5dv4mDVySyMgRjYU9IIUv0bP9K9onr5OP9Q-3cu7A2B177Ac6PDn8Mjr027oKnubUOvUCzJCyMEoZpP8hjGQqjWJGLgqmQYyD13CQ5t7YI1YYXJubKWCtIaodMoxVbh4Xquso_AeFJKCS1i7vkmgeSCxlrLiXzqbGmty96sDtlQKZbUHKMjTHOGjhlmtmhytxQ9WC7I_3VIHH8i2hzysWsFcY6o7goIVAe7cFWV3yFIzhGj-LrW6SJIryR9i3Nx4bpXS0siqxaRP0eJDPToSNAiO7Zkqq8dFDdiHCFEGq2n24-vNzybPB94D42_p_0M7ylVudqXOI2YWFyc5t_gTf6blLWN30nDjaNR7FLkz4sHhwO07O-O3iwufTkNL2wuZ8nwz-F2RZS |
| linkProvider | Wiley-Blackwell |
| linkToHtml | http://cvtisr.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMw1V1Lb9QwEB6VLYJeeEMXChgEEherWcd5GAmhaqHqqrurPRTRnoIzTkSkki3Ntqh_qr-xHudBVwVuPXCL5FES25_HY_vzNwBv_MjYuDsccIFacOvwAq5CNFyksQoCxDQN0CWbiKbTeH9fzVbgvL0LQ7TK1ic6R23mSHvkm4KQRWpn4uPRT05Zo-h0tU2hUcNiNzv7ZZds1YfRJ9u_b4XY_rw33OFNVgGO0q59-AD9OMhNqoyP3iCLdKBM6ueZyv00kJQmPDNxJm2kLdDI3EQyNTbG1-h0VzD17XtvwKq0YI97sDobTWYH3RKPzq1qNXGPK7uWabWMPLFJl6sFzf7LM-CVsPYqO_Ny1Oymve27_1uD3YM7TYDNtuoRcR9WsvIB3Jo0FIKH8PUSIFnDUmOnRYW0Oce0KRyN7Yw5GUmmS8Mo5_eC5bogBv97tsVcu_LKkdjoW06i9xF8uZZqPYZeOS-zdWAyDpQWdgrTEuVAS6UjlFr7njCx9Y-qD-_aHk-wkV6nDCCHSS0aLRILjsSBow-vO9OjWm_kT0YbbZcnjcupkt_93YdXXfEPar9D4k3PT8gmDOnc3bM2T2qUdV_xw9AGf8LrQ7yEv86AhMiXS8riuxMkJx0vEoqz9XRQ_fufJ8Px0D08_XcVXsLtnb3JOBmPprvPYE3YyLIm_m1Ab3F8kj2Hm3i6KKrjF80IZPDtujF8AaoAb8s |
| linkToPdf | http://cvtisr.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMw1V3LbtQwFL0qLarYQFteA324CCQ21mQc52EkhKopI0ZtR7MAUVbBsRMRqWRKMy3qr_F13Os82lGBXRfsRspVMraPr4_jk3MBXvqRRd4dDrgwWnBMeAFXobFcpLEKAmPSNDCu2EQ0mcTHx2q6BL_ab2FIVtnmRJeo7czQO_K-IGSR25no540sYro_enf6g1MFKTppbctp1BA5yC5_4vatejvex7F-JcTo_cfhB95UGOBG4j6ID4wfB7lNlfWNN8giHSib-nmmcj8NJJUMz2ycSWTdwliZ20imFvm-Ns6DxaQ-3vcOrCAllzjHVqbjo-mXbrtHZ1i1s7jHFe5rWl8jT_TpQ2tBTGBxNbxBcW8qNa8zaLcEjh78z523Bvcb4s326pmyDktZuQGrR4204CF8vgZU1qjX2EVRGXppx7QtnLztkjl7SaZLy6gW-JzluiBl_xu2x1wf88qJ2-hZzrr3EXy6lWY9huVyVmZPgck4UFrg0qalkQMtlY6M1Nr3hI0xb6oevG5HPzGNJTtVBjlJajNpkSBQEgeUHrzoQk9rH5I_BW22w580qahKrsa-B7vd5e_Ufyekp56dU0wY0nm8hzFPasR1T_HDEEmh8HoQL2CxCyCD8sUrZfHNGZWTvxcZyGE7HWz__s-T4eHQ_Xj27ybswCoCNzkcTw6ewz2BhLPWA27C8vzsPNuCu-ZiXlRn281kZPD1tiH8G3LneIs |
| openUrl | ctx_ver=Z39.88-2004&ctx_enc=info%3Aofi%2Fenc%3AUTF-8&rfr_id=info%3Asid%2Fsummon.serialssolutions.com&rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&rft.genre=article&rft.atitle=Association+between+visceral+adiposity+index+and+heart+failure%3A+A+cross%E2%80%90sectional+study&rft.jtitle=Clinical+cardiology+%28Mahwah%2C+N.J.%29&rft.au=Zhang%2C+Xinyu&rft.au=Sun%2C+Yijun&rft.au=Li%2C+Ying&rft.au=Wang%2C+Chengwei&rft.date=2023-03-01&rft.issn=0160-9289&rft.eissn=1932-8737&rft.volume=46&rft.issue=3&rft.spage=310&rft.epage=319&rft_id=info:doi/10.1002%2Fclc.23976&rft.externalDBID=10.1002%252Fclc.23976&rft.externalDocID=CLC23976 |
| thumbnail_l | http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/lc.gif&issn=0160-9289&client=summon |
| thumbnail_m | http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/mc.gif&issn=0160-9289&client=summon |
| thumbnail_s | http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/sc.gif&issn=0160-9289&client=summon |